ReiThera opens new viral vector production manufacturing facility 03-Nov-2022 By Rachel Arthur ReiThera has received operational authorization from the Italian Medicines Agency (AIFA) to open a new production area at its facility near Rome for the large-scale production of viral vectors for vaccines and gene therapy.